Biden to receive coronavirus vaccine on Monday as U.S. inoculation
effort mounts
Send a link to a friend
[December 21, 2020]
By David Brunnstrom
WASHINGTON (Reuters) - U.S. President-elect
Joe Biden plans to publicly receive a COVID-19 vaccine injection on
Monday in an effort to boost confidence in its safety ahead of its wide
distribution next year.
Biden has vowed to make the fight against the coronavirus, which has
killed more than 300,000 Americans and infected more than 17 million,
his top priority when he takes office on Jan. 20. At age 78, he is in
the high-risk group for the highly contagious respiratory disease.
Republican President Donald Trump, who lost the Nov. 3 election to his
Democratic rival, frequently downplayed the severity of the pandemic and
oversaw a response health experts say was disorganized and cavalier and
sometimes ignored the science behind disease transmission.
Trump was infected with the virus in the fall and multiple members of
his inner circle and White House staff have also been infected. The
outgoing president, making unsubstantiated claims of widespread
electoral fraud, has focused on trying to overturn his election loss in
recent weeks, even as daily COVID-19 deaths soared.
On Sunday, Trump's campaign said it had filed a petition again asking
the U.S. Supreme Court to upend the election results by overturning
Pennsylvania court rulings involving mail ballots. Some members of
Congress, where agreement was reached on Sunday on a new relief package
in response to the pandemic, dismissed the challenge.
"I think based on the 57 cases and the initial rulings, you know, any
fair-minded person would have to conclude that there's a narrow, there's
a narrow path for the election to be overturned," said Republican
Senator John Kennedy.
U.S. VACCINE ROLLOUT
After the United States authorized a vaccine developed by Pfizer Inc and
German partner BioNTech SE on Dec. 11, distribution of a second approved
vaccine, made by Moderna Inc, began on Saturday.
Initial inoculations have been given to health professionals, and Vice
President Mike Pence, his wife, Karen, and Surgeon General Jerome Adams
received vaccines at a White House event on Friday as the administration
scrambled to build support for what will be a nationwide program.
[to top of second column]
|
President-elect Joe Biden arrives at his transition headquarters in
Wilmington, Delaware, U.S., December 16, 2020. REUTERS/Kevin
Lamarque/Pool
House of Representatives Speaker Nancy Pelosi, Senate Majority
Leader Mitch McConnell and other members of Congress also received
the vaccine on Friday.
A Biden transition official said last week that Biden would receive
a dose of the Pfizer vaccine on Monday, while Vice President-elect
Kamala Harris would likely get the vaccine the week after Biden.
Biden will inherit the logistical challenges of distributing the
vaccine to hundreds of millions of Americans, as well as the task of
persuading people who worry its development was rushed for political
reasons to take it.
Only 61% of respondents in a Reuters/Ipsos poll conducted from Dec.
2 to 8 said they were open to getting vaccinated. That is short of
the 70% officials say is needed to reach herd immunity, either
through exposure or vaccination. Roughly 5% of Americans have been
infected.
Efforts to limit the economic fallout on Americans from the pandemic
were boosted on Sunday when congressional leaders agreed on a $900
billion package to provide the first new aid in months, with votes
likely on Monday.
The measure would be the second-largest stimulus in U.S. history,
following a $2.3 trillion aid bill passed in March. Senate
Democratic leader Chuck Schumer said it would include over $30
billion to support procurement and distribution of the vaccine,
"ensuring it's free and rapidly distributed to everyone."
On Sunday, a U.S. Centers for Disease Control and Prevention
advisory panel recommended that frontline essential workers and
people aged 75 and older be next in line to receive the vaccine.
(Reporting by David Brunnstrom; Editing by Heather Timmons and Peter
Cooney)
[© 2020 Thomson Reuters. All rights
reserved.] Copyright 2020 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |